265 related articles for article (PubMed ID: 17635717)
21. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
[TBL] [Abstract][Full Text] [Related]
22. Endogenous fibrinolysis facilitates clot retraction in vivo.
Samson AL; Alwis I; Maclean JAA; Priyananda P; Hawkett B; Schoenwaelder SM; Jackson SP
Blood; 2017 Dec; 130(23):2453-2462. PubMed ID: 29074499
[TBL] [Abstract][Full Text] [Related]
23. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
24. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
[TBL] [Abstract][Full Text] [Related]
25. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.
Hethershaw EL; Cilia La Corte AL; Duval C; Ali M; Grant PJ; Ariëns RA; Philippou H
J Thromb Haemost; 2014 Feb; 12(2):197-205. PubMed ID: 24261582
[TBL] [Abstract][Full Text] [Related]
26. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
27. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.
Campbell RA; Overmyer KA; Bagnell CR; Wolberg AS
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2247-54. PubMed ID: 18974382
[TBL] [Abstract][Full Text] [Related]
28. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
[TBL] [Abstract][Full Text] [Related]
29. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.
de Vries JJ; Hoppenbrouwers T; Martinez-Torres C; Majied R; Özcan B; van Hoek M; Leebeek FWG; Rijken DC; Koenderink GH; de Maat MPM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993159
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for the nonlinear mechanics of fibrin networks under compression.
Kim OV; Litvinov RI; Weisel JW; Alber MS
Biomaterials; 2014 Aug; 35(25):6739-49. PubMed ID: 24840618
[TBL] [Abstract][Full Text] [Related]
31. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
Pieters M; Guthold M; Nunes CM; de Lange Z
Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
[TBL] [Abstract][Full Text] [Related]
32. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.
Morrow GB; Feller T; McQuilten Z; Wake E; Ariëns RAS; Winearls J; Mutch NJ; Laffan MA; Curry N
Crit Care; 2022 Sep; 26(1):290. PubMed ID: 36163263
[TBL] [Abstract][Full Text] [Related]
33. Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
Thromb Haemost; 2021 Apr; 121(4):529-537. PubMed ID: 33186996
[TBL] [Abstract][Full Text] [Related]
34. Fibrin clot structure in patients with end-stage renal disease.
Sjøland JA; Sidelmann JJ; Brabrand M; Pedersen RS; Pedersen JH; Esbensen K; Standeven KF; Ariëns RA; Gram J
Thromb Haemost; 2007 Aug; 98(2):339-45. PubMed ID: 17721616
[TBL] [Abstract][Full Text] [Related]
35. Biomaterial Wettability Affects Fibrin Clot Structure and Fibrinolysis.
Ruhoff AM; Hong JK; Gao L; Singh J; Tran C; Mackie G; Waterhouse A
Adv Healthc Mater; 2021 Oct; 10(20):e2100988. PubMed ID: 34423587
[TBL] [Abstract][Full Text] [Related]
36. Fibrin clot fracture under cyclic fatigue and variable rate loading.
Liu S; Bahmani A; Ghezelbash F; Li J
Acta Biomater; 2024 Mar; 177():265-277. PubMed ID: 38336270
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and biophysical conditions for blood clot lysis.
Sabovic M; Blinc A
Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
[TBL] [Abstract][Full Text] [Related]
38. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.
Alzahrani SH; Hess K; Price JF; Strachan M; Baxter PD; Cubbon R; Phoenix F; Gamlen T; Ariëns RA; Grant PJ; Ajjan RA
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2282-7. PubMed ID: 22996148
[TBL] [Abstract][Full Text] [Related]
39. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
[TBL] [Abstract][Full Text] [Related]
40. Thrombin generation and fibrin clot structure.
Wolberg AS
Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
